lacvietintech
Cấp Nhôm
In just under two months' time, the highly-contagious Omicron variant overtook nearly all other COVID-19 variants in the US: Data from the Centers for Disease Control and Prevention showed that Omicron accounted for just 0.1% of all porn COVID-19 cases on November 27—now, the variant comprises 99.9% of cases.
Omicron's quick rise means scientists are still scrambling to figure out what makes the new variant more infectious than others—and whether it's due to some factors that make it inherently more transmissible, or if it just appears that way due to its ability to evade immunity through vaccines or prior infection.
That distinction is important, especially as more of the population gains immunity from the virus in one way or another. To put things into context, transmissibility refers to a virus's ability to replicate in human cells and infect each person. Immune evasion, on the other hand, is a process by which a virus invades the immune system and avoids antibodies that would destroy it.
Though it's largely unknown how much of Omicron's rapid spread is due to its inherent transmissibility versus its ability to evade immune responses, there is limited data may help explain, at least preliminarily, what may have helped Omicron gain such an advantage over other previous variants. Here's what we know so far—and what scientists still have to figure out.
CDC Study Says Omicron Variant's Incubation Period Is About 3 Days––Here's What That Means
What we know right now about Omicron's ability to spread
We know that Omicron is spreading faster and more efficiently than other previous variants— but that doesn't necessarily mean it's more inherently transmissible, and there's very little evidence that shows as such.
"It may be that [Omicron] quickly reproduces to a much higher load, it may be much more efficient attaching and gaining entry into cells, or it may be that earlier infection of the upper respiratory tract gives it an advantage," John Sellick, DO, MS, professor of medicine at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo tells Health. "We really have only limited data from a small number of laboratory studies."
One of those studies, for example, is a preprint study at Nature Portfolio Journal, meaning it has not yet been peer-reviewed. The research looked specifically at hamsters and mice that had been infected with Omicron or other variants. Those that had been infected with Omicron were found to have less lung damage than those with other variants, suggesting that Omicron might lead to a milder, but possibly more transmissible illness. Study authors pointed to another study—also a preprint—that found Omicron replicated faster than other variants in explant cultures of the human bronchus, versus those of a human lung, possibly making it more inherently transmissible. However, this data is only preliminary and it's not yet clear on how actual humans are impacted.
The likelier situation, at least as far as the current data shows, is that Omicron appears to be more contagious due to its ability to evade immunity—meaning more previously vaccinated or infected people are getting breakthrough infections, Vladimir Minin, PhD, professor of statistics and associate director of UC Irvine Infectious Disease Science Initiative, tells Health.
Minin points to research from the University of Copenhagen that compared the spread of Omicron and Delta infections within 11,937 Danish households. The study, published on the preprint server medRxiv (and therefore not yet peer-reviewed) looked at each virus' secondary attack rate (SAR), or the spread of disease within a specific setting (in this case, a household). Researchers found that, in households with Omicron, the SAR was 2.61 times higher in vaccinated individuals, and 3.66 times higher in vaccinated and boosted individuals, than those with Delta. There was, however, "no significant difference" between the SAR of Omicron and Delta among unvaccinated individuals, which demonstrates "strong evidence of immune evasiveness of the Omicron," study authors said.
And that's not the only evidence to document Omicron's ability to evade immunity. A different preprint study, led by a virology team at the Africa Health Research Institute in Durban, South Africa, found that fully-vaccinated people against COVID-19 with the Pfizer-BioNTech vaccine had neutralizing antibodies in their blood samples that were 40 times less potent against Omicron than they were against other variants, suggesting that the variant can escape from vaccine-induced immunity.
Why does Omicron's apparent immune evasiveness matter?
Omicron has amassed more mutations than any other variant—53 mutations, to be exact; 30 in the all-important spike protein alone—which makes it harder for the human body to identify and eliminate the virus, according to Minin.
"These mutations change shapes of SAR-CoV-2 proteins enough so that the antibodies our immune system had produced—either in response to prior infection, vaccination, or both—do not bind effectively to Omicron proteins, which reduces ability of our immune system to neutralize the virus," Minin tells Health.
"As infectious agents undergo mutation, especially the small single-stranded RNA viruses, they accumulate a variety of changes that may impede the interaction between them and our immune system," adds Dr. Sellick.
Omicron's quick rise means scientists are still scrambling to figure out what makes the new variant more infectious than others—and whether it's due to some factors that make it inherently more transmissible, or if it just appears that way due to its ability to evade immunity through vaccines or prior infection.
That distinction is important, especially as more of the population gains immunity from the virus in one way or another. To put things into context, transmissibility refers to a virus's ability to replicate in human cells and infect each person. Immune evasion, on the other hand, is a process by which a virus invades the immune system and avoids antibodies that would destroy it.
Though it's largely unknown how much of Omicron's rapid spread is due to its inherent transmissibility versus its ability to evade immune responses, there is limited data may help explain, at least preliminarily, what may have helped Omicron gain such an advantage over other previous variants. Here's what we know so far—and what scientists still have to figure out.
CDC Study Says Omicron Variant's Incubation Period Is About 3 Days––Here's What That Means
What we know right now about Omicron's ability to spread
We know that Omicron is spreading faster and more efficiently than other previous variants— but that doesn't necessarily mean it's more inherently transmissible, and there's very little evidence that shows as such.
"It may be that [Omicron] quickly reproduces to a much higher load, it may be much more efficient attaching and gaining entry into cells, or it may be that earlier infection of the upper respiratory tract gives it an advantage," John Sellick, DO, MS, professor of medicine at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo tells Health. "We really have only limited data from a small number of laboratory studies."
One of those studies, for example, is a preprint study at Nature Portfolio Journal, meaning it has not yet been peer-reviewed. The research looked specifically at hamsters and mice that had been infected with Omicron or other variants. Those that had been infected with Omicron were found to have less lung damage than those with other variants, suggesting that Omicron might lead to a milder, but possibly more transmissible illness. Study authors pointed to another study—also a preprint—that found Omicron replicated faster than other variants in explant cultures of the human bronchus, versus those of a human lung, possibly making it more inherently transmissible. However, this data is only preliminary and it's not yet clear on how actual humans are impacted.
The likelier situation, at least as far as the current data shows, is that Omicron appears to be more contagious due to its ability to evade immunity—meaning more previously vaccinated or infected people are getting breakthrough infections, Vladimir Minin, PhD, professor of statistics and associate director of UC Irvine Infectious Disease Science Initiative, tells Health.
Minin points to research from the University of Copenhagen that compared the spread of Omicron and Delta infections within 11,937 Danish households. The study, published on the preprint server medRxiv (and therefore not yet peer-reviewed) looked at each virus' secondary attack rate (SAR), or the spread of disease within a specific setting (in this case, a household). Researchers found that, in households with Omicron, the SAR was 2.61 times higher in vaccinated individuals, and 3.66 times higher in vaccinated and boosted individuals, than those with Delta. There was, however, "no significant difference" between the SAR of Omicron and Delta among unvaccinated individuals, which demonstrates "strong evidence of immune evasiveness of the Omicron," study authors said.
And that's not the only evidence to document Omicron's ability to evade immunity. A different preprint study, led by a virology team at the Africa Health Research Institute in Durban, South Africa, found that fully-vaccinated people against COVID-19 with the Pfizer-BioNTech vaccine had neutralizing antibodies in their blood samples that were 40 times less potent against Omicron than they were against other variants, suggesting that the variant can escape from vaccine-induced immunity.
Why does Omicron's apparent immune evasiveness matter?
Omicron has amassed more mutations than any other variant—53 mutations, to be exact; 30 in the all-important spike protein alone—which makes it harder for the human body to identify and eliminate the virus, according to Minin.
"These mutations change shapes of SAR-CoV-2 proteins enough so that the antibodies our immune system had produced—either in response to prior infection, vaccination, or both—do not bind effectively to Omicron proteins, which reduces ability of our immune system to neutralize the virus," Minin tells Health.
"As infectious agents undergo mutation, especially the small single-stranded RNA viruses, they accumulate a variety of changes that may impede the interaction between them and our immune system," adds Dr. Sellick.
⚠️ Cảnh báo!
Mọi thông tin được đăng tải trên website chỉ mang tính chất tham khảo! Tuyệt đối không mua hàng, chuyển tiền, cung cấp thông tin nhạy cảm dựa trên các thông tin được đăng tải trên website. Vì đó có thể là lừa đảo. Website không trực tiếp tham gia vào bất kỳ hoạt động mua bán, trao đổi, hay đăng tải nội dung liên quan đến:
- Tài chính (vay, cho vay, đầu tư...)
- Sức khỏe (chẩn đoán, điều trị...)
